|
VaIN1 |
VaIN2+ |
Z/x |
P值 |
Age |
41.5(32,52) |
53(42,59.25) |
-9.806 |
<0.001 |
Concomitant CIN |
|
|
|
|
no |
440(53.8%) |
64(32.3%) |
29.386 |
<0.001 |
yes |
378(46.2%) |
134(67.7%) |
|
|
Cervical lesions histogy |
|
|
|
|
none |
729(78.7%)a
|
180(67.7%)a
|
34.654 |
<0.001 |
LSIL |
64(6.9%)a
|
8(3.0%)b
|
|
|
HSIL |
133(14.4%)a
|
78(29.3%)b
|
|
|
Menstrual status |
|
|
|
|
premenopausal |
614(75.2%) |
94(47.7%) |
57.151 |
<0.001 |
menopausal |
202(24.8%) |
103(52.3%) |
|
|
Cytology results |
|
|
|
|
NILM |
132(14.7%)a
|
30(11.9%)a
|
191.936 |
<0.001 |
ASCUS/LSIL |
703(78.5%)a
|
119(47.0%)b
|
|
|
ASC-H/AGC/HSIL/SCC |
60(6.7%)a
|
104(41.1%)b
|
|
|
HR-HPV results |
|
|
|
|
negative |
106(13.2%) |
9(4.6%) |
11.343 |
0.001 |
positive |
697(86.8%) |
186(95.4%) |
|
|
HR-HPV infection pattern |
|
|
|
|
single |
381(58.2%) |
108(62.1%) |
0.865 |
0.352 |
multiple |
274(41.8%) |
66(37.9%) |
|
|
Gravidity |
|
|
|
|
<3 |
407(52.7%) |
86(43.4%) |
5.358 |
0.021 |
≥3 |
366(47.3%) |
112(56.6%) |
|
|
Parity |
|
|
|
|
<3 |
674(87.2%) |
140(70.4%) |
32.973 |
<0.001 |
≥3 |
99(12.8%) |
59(29.6%) |
|
|
HPV genotype |
|
|
|
|
HPV 16/18 |
183(27.9%) |
108(61.4%) |
68.342 |
<0.001 |
non-type 16/18 hr-HPV |
473(72.1%) |
68(38.6%) |
|
|